Korean J Helicobacter Up Gastrointest Res.  2020 Mar;20(1):21-28. 10.7704/kjhugr.2019.0038.

Helicobacter pylori and Metabolic Diseases

• Kim SE

• KMID: 2501516
• DOI: http://doi.org/10.7704/kjhugr.2019.0038

Abstract

Helicobacter pylori (H. pylori) is one of the most common pathogens that can cause certain gastrointestinal disorders, such as gastritis, peptic ulcers, and gastric cancer. Recently, interest in the systemic effects of H. pylori on extragastric manifestations is increasing. Representative diseases include hematologic, cardiovascular, neurodegenerative, autoimmune, dermatologic, allergic, hepatobiliary, and metabolic diseases. Among them, since the prevalence of metabolic diseases is on the rise worldwide, the relationship between H. pylori infection and metabolic diseases has become an interesting research issue. Many studies have been conducted to clarify any association. However, the results of those studies still remain controversial. This review focuses on recently published studies to investigate the relationship between H. pylori infection and metabolic diseases, including diabetes mellitus, metabolic syndrome, obesity, and non-alcoholic fatty liver disease, and their associated pathophysiology.

Keyword

Diabetes mellitus; Metabolic syndrome; Non-alcoholic fatty liver disease; Obesity